Fear Not the Future Is Now – Bispecific Antibodies brings together clinical and operational experts to examine how oncology groups are adapting to the rapid emergence of bispecific antibody therapies. This webinar will review key bispecific antibody constructs, explore hospital and outpatient care requirements, and address the unique adverse event profiles that demand specialized management strategies. Speakers will also dive into the real-world “nuts and bolts” of current practice, including efficacy, safety considerations, and financial implications for oncology programs.

The session will be moderated by Ashkan Lashkari, MD, an oncologist with Wellness Oncology and MOASC VP, who will guide a dynamic discussion among a multidisciplinary panel.

Discussants include Gregory A. Daniels, MD, PhD, Professor of Medicine at the UC San Diego Moores Cancer Center; Penny Riehl, RN, Outpatient/Inpatient Oncology Nurse Educator and Coordinator for BiTEs Therapy and staff nurse for outpatient infusion units at the VA San Diego Healthcare System; and Anthony Bejjani, MD, FACP, Assistant Clinical Professor at UCLA and Associate Chief at the VA Greater Los Angeles Health System.

Together, the faculty will provide practical, multidisciplinary insights to help oncology teams confidently integrate bispecific antibodies into clinical practice.